管腔型乳腺癌表观扩散系数测量:肿瘤退缩模式是否影响其评估病理缓解的效能
本研究回顾性纳入61例接受新辅助化疗的管腔型乳腺癌患者,比较三种ADC感兴趣区放置方法(单圆、三圆、自由手)在不同肿瘤退缩模式下预测病理完全缓解的效能。结果发现单圆法在全部患者中最佳(AUC=0.863),同心性退缩以单圆法最优(AUC=0.970),巢状或树枝状退缩以自由手法最优(AUC=0.714),混合性退缩以三圆法最优(AUC=0.975)。多因素分析显示雌激素受体、ΔADC%和肿瘤直径缩小率是评估病理完全缓解的独立因素。
要点
- 管腔型乳腺癌新辅助化疗两周期后,ADC测量方法应随肿瘤退缩模式调整。
- 同心性退缩用单圆ROI(AUC=0.970),巢状或树枝状退缩用自由手ROI(AUC=0.714),混合性退缩用三圆ROI(AUC=0.975)。
- ΔADC%、雌激素受体和肿瘤直径缩小率是评估病理完全缓解的独立因素。
核心结论
- 不同肿瘤退缩模式对应的最佳ADC测量ROI放置方法不同;ΔADC%、雌激素受体和肿瘤直径缩小率是评估病理完全缓解的独立因素。
研究设计与样本
- 回顾性研究,纳入61例经组织病理学确诊并接受新辅助化疗的乳腺癌患者,采用扩散加权成像测量ADC值,以病理完全缓解为参考标准。
关键影像表现/征象
- 根据扩散加权成像显示的肿瘤退缩模式分为同心性退缩、巢状或树枝状退缩和混合性退缩。
诊断标准与关键数值
- 全部患者中单圆ROI放置法预测病理完全缓解的AUC=0.863。
- 同心性退缩肿瘤中单圆ROI法预测病理完全缓解的AUC=0.970。
- 巢状或树枝状退缩肿瘤中自由手ROI法预测病理完全缓解的AUC=0.714。
- 混合性退缩肿瘤中三圆ROI法预测病理完全缓解的AUC=0.975。
临床应用与阅片要点
- 新辅助化疗两周期后测量ADC时,宜根据扩散加权成像所示肿瘤退缩模式选择ROI放置方法。
- 同心性退缩肿瘤采用单圆ROI测量ADC。
- 巢状或树枝状退缩肿瘤采用自由手ROI测量ADC。
- 混合性退缩肿瘤采用三圆ROI测量ADC。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To determine which region of interest (ROI) placement method of apparent diffusion coefficient (ADC) measurement has the best performance for predicting pathological complete response (PCR) at two cycles of neoadjuvant chemotherapy (NAC) according to different tumour shrinkage patterns of luminal breast cancer and to assess the evaluative accuracy of ADC value combined with other clinicopathological indicators.
MATERIALS AND METHODS: Sixty-one patients who underwent NAC for histopathologically confirmed breast cancer were enrolled in this retrospective study. The ADC values of different shrinkage patterns (concentric shrinkage, nest or dendritic shrinkage, and mixed shrinkage) for tumours shown by diffusion-weighted imaging (DWI) were measured independently using three ROI placement methods (single-round, three-round, and freehand). Intraclass correlation coefficients (ICCs) were used to assess the interobserver variability in the ADC values. Multivariate logistic regression analysis was performed to identify the independent predictors of PCR.
RESULTS: The best placement method found was single-round ROI in all the patients (AUC=0.863). When analysed separately, the effectiveness results differed: the single-round method was optimal for concentrically shrinking tumours (AUC=0.970); the freehand method was optimal for nest or dendritically shrinking tumours (AUC=0.714); and the three-round method was optimal for mixed shrinking tumours (AUC=0.975). Multivariate logistic analysis showed that oestrogen receptor (ER), ΔADC% and tumour diameter reduction (ΔD%) were independent factors in evaluating the PCR.
CONCLUSION: The methods for measuring ADC values vary across different shrinkage patterns of luminal tumours. ΔADC%, ER and ΔD% were independent factors for evaluating the PCR.
引用
- Zhang D, Zhang Q, Suo S, et al. Apparent diffusion coefficient measurement in luminal breast cancer: will tumour shrinkage patterns affect its efficacy of evaluating the pathological response? Clin Radiol. 2018. PMID: 29970246. doi:10.1016/j.crad.2018.05.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。